Big tech is due to report this week, as job losses mount in the wake of the AI frenzy, and markets watch for ‘bang for buck’ in AI spend.
Naomi James says import terminal option not a foregone conclusion.
Fisher Funds analyst thinks valuer conservative on Summerset’s property.
Marsden Point refinery owner posts first-half loss of $186m.
Primary steelmaking could cease if restructuring doesn’t work, says BlueScope.
Regulator again finds fault with key aspect of price setting process.
Fair value of property portfolio hit, although underlying profit holds up.
New Zealand firm’s Australian expansion brings formal relationship to an end
Lockdowns seen as an unsustainable strategy to fight infection.
The Drug Detection Agency's Omega Laboratories testing facility will relocate.
